ClinicalTrials.Veeva

Menu

Effects of Exercise Training on Cognitive Function and Neurotrophic Factors in Overweight Adults (BrainFit)

U

Universidad Santo Tomas

Status

Completed

Conditions

Cognitive Function
Obesity
Motor Activity

Treatments

Behavioral: Experimental: High Intensity Interval
Behavioral: Plus: High Intensity Interval + Resistance Training
Other: Non-exercise
Behavioral: Resistance training

Study type

Interventional

Funder types

Other

Identifiers

NCT02915913
2016-09-22

Details and patient eligibility

About

The BrainFit Study aims to examine acute effects of High Intensity Interval- vs Resistance or Combined program has benefits on Cognitive Function as well as on secretion and regulation of neurotrophic factors or neurotrophins in a cohort of sedentary, overweight adults (aged 18-30 years) from Bogota, Colombia.

Enrollment

60 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Written informed consent.
  • Interested in improving health and fitness.
  • Central obesity: waist circumference ≥90cm
  • Body mass index ≥ 26 kg/m(2)

Exclusion criteria

  • Systemic infections.
  • Weight loss or gain of >10% of body weight in the past 6 months for any reason.
  • Currently taking medication that suppresses or stimulates appetite.
  • Uncontrolled hypertension: systolic blood pressure 160 mm Hg or diastolic blood pressure 95 mm Hg on treatment.
  • Gastrointestinal disease, including self-reported chronic hepatitis or cirrhosis, any episode of alcoholic hepatitis or alcoholic pancreatitis within past year, inflammatory bowel disease requiring treatment in the past year, recent or significant abdominal surgery (e.g., gastrectomy).
  • Asthma.
  • Diagnosed diabetes (type 1 or 2), fasting impaired glucose tolerance (blood glucose 118 mg/dL), or use of any anti-diabetic medications.
  • Currently taking antidepressant, steroid, or thyroid medication, unless dosage is stable (no change for 6 months).
  • Any active use of illegal or illicit drugs.
  • Current exerciser (>30 min organized exercise per week).
  • Indication of unsuitability of current health for exercise protocol (PARQ).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Single Blind

60 participants in 4 patient groups, including a placebo group

High Intensity Interval
Experimental group
Description:
One session for 30-60 minutes of high intensity aerobic exercise
Treatment:
Behavioral: Experimental: High Intensity Interval
Resistance training
Experimental group
Description:
One session for 30-60 minutes of resistance exercise
Treatment:
Behavioral: Resistance training
Plus: High Intensity Interval + Resistance Training
Experimental group
Description:
One session for 30-60 minutes of high intensity aerobic exercise and resistance exercise
Treatment:
Behavioral: Plus: High Intensity Interval + Resistance Training
Non-exercise
Placebo Comparator group
Description:
Non-exercise
Treatment:
Other: Non-exercise

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems